<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03484091</url>
  </required_header>
  <id_info>
    <org_study_id>OrthoTU09</org_study_id>
    <nct_id>NCT03484091</nct_id>
  </id_info>
  <brief_title>Comparison of Single Intra-articular Injection of Hyruan-One With Hylan G-F 20 in Knee Osteoarthritis</brief_title>
  <official_title>Comparison of Single Intra-articular Injection of Hyruan-One With Hylan G-F 20 in Knee Osteoarthritis: A Randomized Double-blind, Saline-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thammasat University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thammasat University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We compare the efficacy of intra-articular injection of Hyruan-One with Hylan G-F 20 and
      placebo (NSS) controlled in a double-blind RCT.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2018</start_date>
  <completion_date type="Anticipated">June 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A double-blind, placebo controlled RCT</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain level</measure>
    <time_frame>6 months after injection</time_frame>
    <description>visual analog scale for pain (0-100) in between groups</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from pre-injection pain level at 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>compare visual analog scale for pain (0-100) between pre-injection and post-injection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain level in any time pints</measure>
    <time_frame>post-injection 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24 weeks</time_frame>
    <description>visual analog scale for pain (0-100)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified WOMAC</measure>
    <time_frame>post-injection 2 weeks, 1, 2, 3,4, 5, 6 months</time_frame>
    <description>measure modified WOMAC score (0-96)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lequesne index</measure>
    <time_frame>post-injection 2 weeks, 1, 2, 3,4, 5, 6 months</time_frame>
    <description>measure Lequesne index for knee osteoarthritis (4-24)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36</measure>
    <time_frame>post-injection 2 weeks, 1, 2, 3,4, 5, 6 months</time_frame>
    <description>measure short from health survey 36 items</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time up and go test</measure>
    <time_frame>post-injection 1, 3, 6 months</time_frame>
    <description>recorded time Up and Go test (minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>post-injection 1, 2 weeks</time_frame>
    <description>assess complications after injection by phone</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">276</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>H group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose of Hyruan-One 3 mL intra-articular knee injection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>S group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single dose of Hylan G-F 20 (Synvisc) 6 mL intra-articular knee injection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>N group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single dose of normal saline 6 mL intra-articular knee injection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyruan-One</intervention_name>
    <description>single dose intra-articular injection</description>
    <arm_group_label>H group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hylan G-F 20</intervention_name>
    <description>single dose intra-articular injection</description>
    <arm_group_label>S group</arm_group_label>
    <other_name>Synvisc</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>single dose intra-articular injection</description>
    <arm_group_label>N group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic primary knee osteoarthritis with failed conservative treatment at least 3
             months

          -  Kellgren-Lawrence grade I-III

          -  Gave informed consent

          -  Can do questionnaires

        Exclusion Criteria:

          -  Severe deformity (varus or values from mechanical axis more than 5 degrees

          -  Allergy to hyaluronic acid

          -  Pain on hip or ankle

          -  Post-traumatic or post surgery of lower extremity

          -  Post infection of knee

          -  Previous hyaluronic acid injection within 6 months

          -  Pregnancy or lactation

          -  Underlying Rheumatoid arthritis, stroke, malignancy, venous occlusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nattapol Tammachote, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thammasat University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nattapol Tammachote</last_name>
    <phone>+662-9269775</phone>
    <email>tammachotemd@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Thammasat University</name>
      <address>
        <city>Khlong Luang</city>
        <state>Pathum Thani</state>
        <zip>12120</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nattapol Tammachote, MD</last_name>
      <phone>6629269775</phone>
      <email>tammachotemd@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2018</study_first_submitted>
  <study_first_submitted_qc>March 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2018</study_first_posted>
  <last_update_submitted>March 24, 2018</last_update_submitted>
  <last_update_submitted_qc>March 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Thammasat University</investigator_affiliation>
    <investigator_full_name>Supakit Kanitnate</investigator_full_name>
    <investigator_title>Department of orthopaedics</investigator_title>
  </responsible_party>
  <keyword>Hyruan-One</keyword>
  <keyword>Hylan G-F 20</keyword>
  <keyword>Hyaluronic acid</keyword>
  <keyword>Knee osteoarthritis</keyword>
  <keyword>Pain level</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hylan</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

